CMS recently finalized new policies for Medicare drug plans, effective January 1, 2019. These policies broaden a partnership with providers to address the opioid crisis while maintaining access to needed medications. It’s very important that ACO participants understand the new policies to minimize additional burden on them and their patients. Together, there can be progress made in addressing many aspects of the opioid epidemic.
For more information on CMS opioid policies, see the below available resources:
• A Prescriber’s Guide to the New Medicare Part D Opioid Overutilization Policies for 2019
• Information for Prescribers (including slide deck and tip sheet)
Please review the Reducing Opioid Misuse letter mailed to all Medicare fee-for-service providers for more details.